Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council
EQS-News: MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council
EQS-News: MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Agilent Announces Cash Dividend of 21 Cents Per Share:
Agilent Announces Cash Dividend of 21 Cents Per Share


Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on October 26, 2022, to all shareholders of record as of the close of

LivaNova to Announce Third-Quarter 2022 Results: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Announce Third-Quarter 2022 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third-quarter 2022 results on Wednesday, November 2, 2022, at 12

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
BIOCORP gibt anlässlich der EASD-Jahrestagung die CE-Kennzeichnung von SoloSmart® bekannt, einem medizinischen Hilfsmittel für SANOFI Solostar®-Pens: https://mms.businesswire.com/media/20191211005828/en/639213/5/Logo_Biocorp.jpg
BIOCORP gibt anlässlich der EASD-Jahrestagung die CE-Kennzeichnung von SoloSmart® bekannt, einem medizinischen Hilfsmittel für SANOFI Solostar®-Pens


fcAufsichtsrechtliche Meldungen:



BIOCORP (FR0012788065 – ALCOR / PEA‐PME-qualifiziert), ein französisches Unternehmen, das auf die Konzeption, Entwicklung und Herstellung von innovativen

BIOCORP announces the CE marking of SoloSmart®, an accessory medical device for SANOFI Solostar® pens at the occasion of EASD: https://mms.businesswire.com/media/20191211005828/en/639213/5/Logo_Biocorp.jpg
BIOCORP announces the CE marking of SoloSmart®, an accessory medical device for SANOFI Solostar® pens at the occasion of EASD


Regulatory News:



BIOCORP (FR0012788065 – ALCOR / Eligible PEA‐PME), a French company specialized in the design, development, and manufacturing of innovative medical devices, and SANOFI announced

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
LivaNova Board Appoints Brooke Story as a New Director: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Board Appoints Brooke Story as a New Director


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the LivaNova Board of Directors appointed Brooke Story to the Board, effective September 15

Thomas Jefferson University and Acadia Healthcare Establish Primary Affiliation Agreement: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Thomas Jefferson University and Acadia Healthcare Establish Primary Affiliation Agreement


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and Thomas Jefferson University today announced that Acadia’s Belmont Behavioral Health Hospital has entered into a formal affiliation agreement with

Agilent Earns Great Place to Work® Certification in 20 Countries and Regions:
Agilent Earns Great Place to Work® Certification in 20 Countries and Regions


Agilent Technologies Inc. (NYSE: A) today announced the company has achieved Great Place to Work® Certification™ in 20 countries and regions, a recognition that distinguishes Agilent as a top

Simulations Plus to Present at Sidoti Fall Small Cap Investor Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus to Present at Sidoti Fall Small Cap Investor Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that chief executive officer Shawn

Select Acadia Healthcare Hospitals to Participate in Clinical Trial for Acute Suicidal Ideation and Behavior in Major Depression Drug: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Select Acadia Healthcare Hospitals to Participate in Clinical Trial for Acute Suicidal Ideation and Behavior in Major Depression Drug


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that select facilities from its network of acute care behavioral health hospitals will participate in a registration directed trial to

STAAR Surgical Patient Awareness Campaign Launched In New York: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Patient Awareness Campaign Launched In New York


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided an update on activities

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Agilent Announces Thought Leader Award to Professor Christoph Herwig: https://unsplash.com/photos/MJX7-BAdkt0
Agilent Announces Thought Leader Award to Professor Christoph Herwig


Agilent Technologies Inc. (NYSE: A) today announced Christoph Herwig has been selected to receive a prestigious Agilent Thought Leader Award. A prominent researcher in the field of bioprocess

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Fortune Ranks Agilent Among Top Workplaces in Health Care:
Fortune Ranks Agilent Among Top Workplaces in Health Care


Agilent Technologies Inc. (NYSE: A) today announced that the company has been named a “Best Workplace in Health Care” in the United States by Fortune magazine. Agilent’s number 17 ranking is based

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc